LogicBio Therapeutics Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- LogicBio Therapeutics's estimated annual revenue is currently $4M per year.
- LogicBio Therapeutics received $50.0M in venture funding in June 2017.
- LogicBio Therapeutics's estimated revenue per employee is $89,556
- LogicBio Therapeutics's total funding is $129.5M.
- LogicBio Therapeutics has 45 Employees.
- LogicBio Therapeutics grew their employee count by 15% last year.
- LogicBio Therapeutics currently has 3 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Cell Signaling ...||$75.6M||488||N/A||N/A|
What Is LogicBio Therapeutics?
We are a genome editing company developing genetic medicines for the fight against rare pediatric diseases. GeneRide is a promoterless and nuclease-free approach to gene insertion which may improve the safety profile of AAV based gene therapies With GeneRide, the therapeutic gene is site-specifically integrated into the genome allowing durable gene expression in dividing cells and mature tissues. Furthermore, therapeutic gene expression is regulated by the targeted locus so production can be limited to specific cell types.keywords:N/A
Number of Employees
Employee Growth %
|Sven Loebrich||Director Process Development|
|Marcia Farrow||Associate Director Clinical Trial Operations|
|Kyle Chiang||VP Product Strategy||Email Available|
|Jessie Haigh||Executive Assistant to the CEO and Office Manager||Email Available|
|Chris Cummings||Principal Research Associate|
|Jing Liao||Associate Director|
|Nelson Chau||VP, Discovery Biology and Translational Research||Email Available|
|Kenneth Huttner||Vice President Clinical Development|
|Frederic Chereau||Chief Executive Officer||Email Available|
LogicBio Therapeutics News
LogicBio Therapeutics, Inc. (LOGC) has been garnering interest of retail and insitutional invenstors alike as the shares have seen its VMA ...
Shares of LogicBio Therapeutics Inc (NASDAQ:LOGC) have been given a consensus recommendation of “Buy” by the six brokerages that are ...
On its latest session, LogicBio Therapeutics, Inc. ($LOGC) opened at 12.0, reaching a high of 12.0 and a low of 10.88 before closing at a price ...
LogicBio Therapeutics Funding
LogicBio Therapeutics Executive Hires
|2018-05-24||Dean Falb||chief scientific officer||Article|